Your browser doesn't support javascript.
loading
Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration.
Ku, Cristy A; Hull, Sarah; Arno, Gavin; Vincent, Ajoy; Carss, Keren; Kayton, Robert; Weeks, Douglas; Anderson, Glenn W; Geraets, Ryan; Parker, Camille; Pearce, David A; Michaelides, Michel; MacLaren, Robert E; Robson, Anthony G; Holder, Graham E; Heon, Elise; Raymond, F Lucy; Moore, Anthony T; Webster, Andrew R; Pennesi, Mark E.
Afiliação
  • Ku CA; Casey Eye Institute, Oregon Health & Science University, Portland.
  • Hull S; University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England.
  • Arno G; University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England.
  • Vincent A; Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Carss K; National Health Service Blood and Transplant Centre, Department of Haematology, University of Cambridge, Cambridge, England6National Institute for Health Research BioResource: Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, England.
  • Kayton R; Pathology Department, Oregon Health & Science University, Portland.
  • Weeks D; Pathology Department, Oregon Health & Science University, Portland.
  • Anderson GW; Histopathology Department, Great Ormond Street Hospital for Children, London, England.
  • Geraets R; Sanford Children's Health Research Center, Sanford Research, Sioux Falls, South Dakota.
  • Parker C; Sanford Children's Health Research Center, Sanford Research, Sioux Falls, South Dakota.
  • Pearce DA; Sanford Children's Health Research Center, Sanford Research, Sioux Falls, South Dakota10Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls.
  • Michaelides M; University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England.
  • MacLaren RE; Moorfields Eye Hospital, London, England11Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, England12Oxford University Hospitals National Health Service Foundation Trust, Oxford, England.
  • Robson AG; University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England.
  • Holder GE; University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England.
  • Heon E; Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Raymond FL; National Health Service Blood and Transplant Centre, Department of Haematology, University of Cambridge, Cambridge, England6National Institute for Health Research BioResource: Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, England13Cambridge Institute for Medi
  • Moore AT; University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England14Department of Ophthalmology, University of California, San Francisco Medical School, San Francisco.
  • Webster AR; University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England.
  • Pennesi ME; Casey Eye Institute, Oregon Health & Science University, Portland.
JAMA Ophthalmol ; 135(7): 749-760, 2017 07 01.
Article em En | MEDLINE | ID: mdl-28542676
ABSTRACT
Importance Mutations in genes traditionally associated with syndromic retinal disease are increasingly found to cause nonsyndromic inherited retinal degenerations. Mutations in CLN3 are classically associated with juvenile neuronal ceroid lipofuscinosis, a rare neurodegenerative disease with early retinal degeneration and progressive neurologic deterioration, but have recently also been identified in patients with nonsyndromic inherited retinal degenerations. To our knowledge, detailed clinical characterization of such cases has yet to be reported.

Objective:

To provide detailed clinical, electrophysiologic, structural, and molecular genetic findings in nonsyndromic inherited retinal degenerations associated with CLN3 mutations. Design, Setting, and

Participants:

A multi-institutional case series of 10 patients who presented with isolated nonsyndromic retinal disease and mutations in CLN3. Patient ages ranged from 16 to 70 years; duration of follow-up ranged from 3 to 29 years. Main Outcomes and

Measures:

Longitudinal clinical evaluation, including full ophthalmic examination, multimodal retinal imaging, perimetry, and electrophysiology. Molecular analyses were performed using whole-genome sequencing or whole-exome sequencing. Electron microscopy studies of peripheral lymphocytes and CLN3 transcript analysis with polymerase chain reaction amplification were performed in a subset of patients.

Results:

There were 7 females and 3 males in this case series, with a mean (range) age at last review of 37.1 (16-70) years. Of the 10 patients, 4 had a progressive late-onset rod-cone dystrophy, with a mean (range) age at onset of 29.7 (20-40) years, and 6 had an earlier onset rod-cone dystrophy, with a mean (range) age at onset of 12.1 (7-17) years. Ophthalmoscopic examination features included macular edema, mild intraretinal pigment migration, and widespread atrophy in advanced disease. Optical coherence tomography imaging demonstrated significant photoreceptor loss except in patients with late-onset disease who had a focal preservation of the ellipsoid zone and outer nuclear layer in the fovea. Electroretinography revealed a rod-cone pattern of dysfunction in 6 patients and were completely undetectable in 2 patients. Six novel CLN3 variants were identified in molecular analyses. Conclusions and Relevance This report describes detailed clinical, imaging, and genetic features of CLN3-associated nonsyndromic retinal degeneration. The age at onset and natural progression of retinal disease differs greatly between syndromic and nonsyndromic CLN3 disease, which may be associated with genotypic differences.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / DNA / Glicoproteínas de Membrana / Acuidade Visual / Chaperonas Moleculares / Mutação Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / DNA / Glicoproteínas de Membrana / Acuidade Visual / Chaperonas Moleculares / Mutação Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Ano de publicação: 2017 Tipo de documento: Article